Access to advanced cancer technologies is unevenly distributed, with disparities evident between different regions and socioeconomic groups. High costs, lack of infrastructure, and insufficient healthcare resources in low-income areas limit the availability of cutting-edge diagnostic and treatment options. Efforts to democratize access to these technologies are essential for ensuring equitable cancer care.
